Astrazeneca Pharma India Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 416.15 | 395.87 | 391.86 |
| Operating Expense | 355.46 | 407.01 | 333.81 |
| Net Profit | 38.43 | -11.79 | 39.48 |
| Net Profit Margin | 9.23 | -2.98 | 10.08 |
| Earning Per Share | 16.37 | -4.72 | 15.79 |
| EBIDTA | 62.79 | 2.98 | 58.69 |
| Effective Tax Rate | 24.22 | -96.50 | 26.74 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 416.15 |
| Operating Expense | 355.46 |
| Net Profit | 38.43 |
| Net Profit Margin | 9.23 |
| Earning Per Share | 16.37 |
| EBIDTA | 62.79 |
| Effective Tax Rate | 24.22 |
Invest in Astrazeneca Pharma India Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,295.53 | 1,002.97 | 805.60 |
| Operating Expenses Annual | 1,111.08 | 837.85 | 719.42 |
| Operating Profit Annual | 235.68 | 150.99 | 100.94 |
| Interest Annual | 1.20 | 0.63 | 0.95 |
| Depreciation | 14.81 | 16.26 | 13.31 |
| Net Profit Annual | 161.51 | 99.29 | 61.60 |
| Tax Annual | 58.03 | 34.81 | 21.44 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,295.53 |
| Operating Expenses Annual | 1,111.08 |
| Operating Profit Annual | 235.68 |
| Interest Annual | 1.20 |
| Depreciation | 14.81 |
| Net Profit Annual | 161.51 |
| Tax Annual | 58.03 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 500.34 | 448.42 | 352.34 |
| Cash Flow from Operations | 27.87 | 58.29 | 100.80 |
| Cash Flow from Investing | 21.74 | 18.11 | 4.74 |
| Cash Flow from Financing | -44.38 | -24.48 | -9.46 |
| Cash Flow at the End | 505.57 | 500.34 | 448.42 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 500.34 |
| Cash Flow from Operations | 27.87 |
| Cash Flow from Investing | 21.74 |
| Cash Flow from Financing | -44.38 |
| Cash Flow at the End | 505.57 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 18.19 | 18.82 | 12.53 |
| PBIT Margin (%) | 17.04 | 17.20 | 10.43 |
| PBT Margin (%) | 2.84 | -10.09 | -0.54 |
| Net PROFIT Margin (%) | 12.47 | 9.90 | 7.65 |
| Return On Networth / Equity (%) | 24.84 | 22.95 | 12.73 |
| Return On Networth /Employed (%) | 33.26 | 30.47 | 16.76 |
| Return On Assets (%) | 24.31 | 17.52 | 12.31 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.02 |
| Asset Turnover Ratio (%) | 1.95 | 1.77 | 1.61 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 18.19 |
| PBIT Margin (%) | 17.04 |
| PBT Margin (%) | 2.84 |
| Net PROFIT Margin (%) | 12.47 |
| Return On Networth / Equity (%) | 24.84 |
| Return On Networth /Employed (%) | 33.26 |
| Return On Assets (%) | 24.31 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 1.95 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 66.68 | 68.86 | 74.49 |
| Total Current Assets Annual | 932.71 | 835.47 | 705.67 |
| Non Current Assets Annual | 145.32 | 149.40 | 150.89 |
| Total Shareholders Funds Annual | 711.92 | 588.69 | 511.39 |
| Total Assets Annual | 1,078.03 | 984.87 | 856.56 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 66.68 |
| Total Current Assets Annual | 932.71 |
| Non Current Assets Annual | 145.32 |
| Total Shareholders Funds Annual | 711.92 |
| Total Assets Annual | 1,078.03 |
No Data Availabe
